Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ResMed.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: Star biotech stocks are going cheap – or cheaper than they were
Health & Biotech
Health Check: More healthcare ‘reverse ferrets’ from Trump’s razor gang
Health & Biotech
Health Check: Half-price sale as brokers ring the bell on Neuren shares
Health & Biotech
Health Check: Brokers slash Cochlear valuations as customers hold tight on product upgrades
Health & Biotech
Health Check: Good golly Miss Molly! Emyria says Ecstasy works for PTSD, months after treatment
Health & Biotech
Health Check: Fisher & Paykel Healthcare shares tumble after Trump tariff king-hit
Health & Biotech
Scott Power: Mach7 launches $5M buyback, reconfirms guidance
Health & Biotech
Health Check: Did the earth move for you? The world shifts on its axis as it enters the Trump era mark two
Experts
Hot Money Monday: Analyst spots two potential long-term ASX winners
Health & Biotech
Health Check: Biotech’s forgotten tortoises pick up the pace as sector emerges from two-year slump
Health & Biotech
Health Check: ASX sleep company emerges from slumber with a revenue and earnings upgrade
Health & Biotech
Health Check: Painchek strives to Make American Aged Folk Comfortable Again
Health & Biotech
Biocurious: From drug prices to efficiency drives, ASX biotechs await the ‘Trumpcare’ health fallout
Experts
Hot Money Monday: Why these 12 ASX stocks could score big under Trump’s trade threats
Experts
CRITERION: Share valuations look overheated, but it’s a tale of two sectors
Health & Biotech
Health Check: Sleep-maker Resmed recovers from ‘nonsense’ sell-off spurred by rise of fat-busting drugs
News
